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Abstract
 
Macrophages are activated from a resting state by a combination of cytokines and microbial
products. Microbes are often sensed through Toll-like receptors signaling through MyD88. We
used large-scale microarrays in multiple replicate experiments followed by stringent statistical
analysis to compare gene expression in wild-type (WT) and MyD88
 
 
 
/
 
  
 
macrophages. We con-
firmed key results by quantitative reverse transcription polymerase chain reaction, Western
blot, and enzyme-linked immunosorbent assay. Surprisingly, many genes, such as inducible nitric
oxide synthase, IRG-1, IP-10, MIG, RANTES, and interleukin 6 were induced by interferon
(IFN)-
 
  
 
from 5- to 100-fold less extensively in MyD88
 
 
 
/
 
  
 
macrophages than in WT macro-
phages. Thus, widespread, full-scale activation of macrophages by IFN-
 
  
 
requires MyD88.
Analysis of the mechanism revealed that MyD88 mediates a process of self-priming by which
resting macrophages produce a low level of tumor necrosis factor. This and other factors lead to
 
basal activation of nuclear factor 
 
 
 
B, which synergizes with IFN-
 
  
 
for gene induction. In contrast,
infection by live, virulent 
 
Mycobacterium tuberculosis
 
 (Mtb) activated macrophages largely
through MyD88-independent pathways, and macrophages did not need MyD88 to kill Mtb in
vitro. Thus, MyD88 plays a dynamic role in resting macrophages that supports IFN-
 
 
 
–dependent
activation, whereas macrophages can respond to a complex microbial stimulus, the tubercle
bacillus, chiefly by other routes.
Key words: macrophage activation • Toll-like receptors • innate immunity • NF-
 
 
 
B • 
microarray gene expression analysis
 
Introduction
 
In a standard view of macrophage activation, macrophages
start out in a resting state and are driven synergistically by
host- and pathogen-derived signals to a state of enhanced
antimicrobial activity against facultative or obligate intra-
 
cellular pathogens (1–5). IFN-
 
  
 
is the principal but not the
sole  host-derived signal for macrophage activation (6).
 
Mycobacterium tuberculosis
 
 (Mtb) is a prime example of a
pathogen whose control by the host is a hallmark of macro-
phage activation, and the protective role of IFN-
 
  
 
in experi-
mental tuberculosis is well established (7). Host products
that can synergize with IFN-
 
  
 
to activate macrophages
include IFN-
 
 
 
, IFN-
 
  
 
(8, 9), membrane-associated or
soluble TNF (9–11), and CD40 ligand (12). Pathogen-
derived macrophage-activating stimuli are diverse and sig-
nal via numerous receptors including Toll-like receptors
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Abbreviations used in this paper:
 
 BMM
 
 
 
, bone marrow–derived macro-
phages; EMSA, electrophoretic mobility shift assay; FPR, formyl peptide
receptor; iNOS, inducible nitric oxide synthase; IRG1, immune responsive
gene 1; LAM, lipoarabinomannan; MARCO, macrophage receptor with
collagenous domain; MOI, multiplicity of infection; Mtb, 
 
Mycobacterium
tuberculosis
 
; NF, nuclear factor; NO, nitric oxide; qRT-PCR, quantitative
RT-PCR; SAA3, serum amyloid A; TLR, Toll-like receptor.T
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(TLRs) to activate transcription of genes that regulate in-
nate and adaptive immune responses. Such genes encode
cytokines, chemokines, costimulatory molecules, and en-
zymes like inducible nitric oxide synthase (iNOS; 13).
The intracellular adaptor molecules MyD88, TIRAP/
MAL, and TICAM-1 transduce signals from TLRs by link-
ing TLRs to IL-1R–associated protein kinase. IL-1R–asso-
ciated protein kinase initiates a signal cascade culminating
in activation of MAP kinases, PI3 kinase, and nuclear factor
(NF)-
 
 
 
B (14–18). MyD88 integrates signals from multiple
TLRs. MyD88 deficiency impairs the macrophage re-
sponse to several bacterial products (19) and MyD88-defi-
cient mice were highly susceptible to infection with 
 
Listeria
monocytogenes
 
, 
 
Staphylococcus aureus
 
, and 
 
Toxoplasma gondii
 
(20–22). However, killing of 
 
L. monocytogenes
 
 by activated
macrophages occurred by MyD88-independent mecha-
nisms (23). Moreover, MyD88 deficiency improved resis-
tance against polymicrobial sepsis, indicating both that
MyD88-dependent responses can be deleterious and that
MyD88-independent antibacterial mechanisms exist (24).
Mycobacterial cell wall glycolipid lipoarabinomannan (LAM),
mannosylated phosphatidylinositol, and a 19-kD Mtb lipo-
protein were characterized as TLR2 agonists, whereas an
undefined cell-associated and heat-labile moiety of live
Mtb acted via TLR4 (25, 26).
There have been many studies of the regulation of indi-
vidual genes in macrophages by subcellular microbial prod-
ucts via the TLR/MyD88 signal transduction pathway.
However, there have apparently been no studies of the role
of MyD88 in macrophage activation defined in terms of
antimicrobial activity, induced by intact, virulent bacteria,
and monitored by analysis of overall gene regulation. Here
we compared the expression of 
 
 
 
11,000 genes by primary
bone marrow–derived macrophages (BMM
 
 
 
) from both
WT and MyD88-deficient (MyD88
 
 
 
/
 
 
 
) mice in response
to IFN-
 
  
 
alone and in response to infection with live, viru-
lent Mtb in the presence or absence of IFN-
 
 
 
. Three sur-
prising findings emerged that suggest the need to revise the
current understanding of macrophage activation. First,
macrophages operationally considered to be “resting” in
culture undergo active self-priming for activation, and this
process is dependent on MyD88. Second, although the ca-
nonical IFN-
 
  
 
signaling pathway does not involve MyD88,
the expression of many genes in macrophages in response
to IFN-
 
  
 
is extensively dependent on MyD88, at least in
part due to the impact of self-priming. Third, the majority
of transcriptional responses of macrophages to live, virulent
Mtb do not require MyD88. This implies either that TLRs
are not the major receptors for recognizing intact, live
Mtb, or that TLR-dependent responses to Mtb involve
mostly MyD88-independent signaling pathways.
 
Materials and Methods
 
Activation and Infection of Macrophages.
 
Macrophages were col-
lected in six independent experiments from 8–10-wk-old WT
C57BL/6 
 
  
 
129/SvJ mice and from MyD88
 
 
 
/
 
  
 
mice on the same
background (six mice per experiment). The mice have been back-
crossed six times to the C57BL/6 background. Bone marrow cells
were differentiated into macrophages, treated with IFN-
 
  
 
or not,
and infected with Mtb from early log phase cultures of a low pas-
sage clinical isolate (strain 1254; American Type Culture Collec-
tion 51910) as previously described (27). Intracellular survival of
Mtb and measurement of nitrite in the conditioned media were as
reported (27). Bone marrow cells were seeded in 175 cm
 
2 
 
tissue
culture flasks (Nunclon; Nalgene), 25 cm
 
2 
 
tissue culture flasks
(Corning), or 24-well tissue culture plates (Corning) at 10
 
5 
 
cells/
cm
 
2 
 
and 0.25 ml medium/cm
 
2
 
, unless stated otherwise. DMEM
was purchased from GIBCO BRL and FBS was purchased from
Hyclone. All media, FBS, and buffers were tested for LPS contam-
ination using a 
 
Limulus
 
 amebocyte lysate test kit (Bio Whittaker
Inc.) and the LPS content was 
 
 
 
20 pg/ml.
 
Array Hybridization.
 
24 h after infection, monolayers were
lysed with Trizol (GIBCO BRL) and total RNA was isolated.
After treatment with DNase I (Ambion) and purification
(RNAeasy; QIAGEN), 2–3 
 
 
 
g RNA was reverse transcribed
(Superscript II; GIBCO BRL) with a T7-polyT primer and
cDNA was transcribed in the presence of biotinylated UTP and
CTP (Enzo). Hybridization to GeneChip oligonucleotide arrays
(Mu11KsubA, B) and scanning (Gene-Array Scanner) followed
Affymetrix, Inc. protocols.
 
Data Processing.
 
Primary image analysis of the arrays was per-
formed using GeneChip Microarray Analysis Suite version 5.0
(Affymetrix, Inc.) and images were scaled to an average hybridiza-
tion intensity (average difference) of 250. Data analysis was per-
formed using GeneSpring 4.1 software (Silicon Genetics). All
measurements on each chip were divided by the 50th percentile
value of that chip. Each gene was compared with its control by di-
viding its intensity by the average intensity of that gene in the six
control samples (untreated WT macrophages). Data from six inde-
pendent replicates were used to perform a Wilcoxon two-sample
rank test for each gene. Only genes with an Affymetrix, Inc.
“present call” in at least one of the two conditions compared were
included in the analysis. A gene was considered “regulated” com-
pared with control if its expression changed across the six experi-
ments with P 
 
  
 
0.05. To identify MyD88-dependent and
MyD88-independent genes, expression levels (absolute signal in-
tensities of normalized samples) and regulation factors (absolute
signal intensities in response to a stimulus divided by signal intensi-
ties of untreated samples) were tested with a Wilcoxon two-sam-
ple rank test for each gene in WT versus MyD88
 
 
 
/
 
  
 
macrophages.
 
Immunocytology.
 
2 
 
  
 
10
 
4
 
/ml macrophages in 1 ml were cul-
tured on 13-mm diameter glass coverslips in 24-well plates con-
taining complete medium. 0.6 
 
 
 
g/ml anti–mouse TNF antibody
(R&D Systems) was added to WT cells, 50 pg/ml mouse TNF
(R&D Systems) was added to MyD88
 
 
 
/
 
  
 
cells, or cells were left
untreated. 24 h after incubation at 37
 
 
 
C, medium was removed
and cells were washed with PBS and fixed with 1% paraformalde-
hyde in cacodylate buffer, pH 7.4 (75 mM sodium cacodylate,
0.72% sucrose), for 10 min at room temperature. Cells were then
washed with PBS and permeabilized with 0.05% Triton X-100 in
PBS for 4 min at room temperature. Coverslips were washed
twice in PBS and once in distilled water, inverted, and mounted
in 90% glycerol in water on a glass slide.
 
Western Blot.
 
Cells cultured and stimulated with 100 U/ml
IFN-
 
  
 
for the indicated time were lysed with buffer containing
25 mM TrisCl, 1 mM EDTA, 5 mM MgCl
 
2
 
, 1 mM DTT, 100
mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM PMSF, and 5
 
 
 
g/ml each of leupeptin, aprotinin, and pepstatin. Cell lysates
were boiled for 5 min in reducing SDS-PAGE sample buffer,
subjected to 7.5% SDS-PAGE, and transferred to a 0.2-
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nitrocellulose membrane (Schleicher & Schuell) in 20% metha-
nol, 25 mM Tris, and 192 mM glycine, pH 8.3. The membrane
was blocked with 5% milk, blotted with anti–mouse iNOS (28),
or anti–mouse pY-STAT1 and anti–mouse STAT1 antibody
(Cell Signaling Technology), followed by secondary antibody
coupled to horseradish peroxidase (1:10,000; Amersham Bio-
sciences). Bound antibody was detected by enhanced chemilumi-
nescence (NEN Life Science Products).
 
Real-Time Quantitative RT-PCR (qRT-PCR).
 
The 5
 
  
 
3
 
  
 
nu-
clease activity of Taq polymerase was applied for the detection of
PCR-amplified nucleic acids. Standard curves were generated for
each gene product using plasmid dilution series containing the
target sequences. Probes were synthesized by Biosearch Technol-
ogies and labeled with the reporter dye FAM at the 5
 
  
 
end and
the quencher Black Hole Quencher at the 3
 
  
 
end. Primer and
probe sequences are listed in Table S3, which is available at http://
www.jem.org/cgi/content/full/jem.20030603/DC1. 100 ng RNA
was transcribed into cDNA with gene-specific primers in 20 
 
 
 
l
using 50 U MuLV reverse transcriptase (PerkinElmer). cDNA
was diluted to 1,000 
 
 
 
l. PCR was performed in a volume of 15
 
 
 
l on the ABI PRISM 7900HT sequence detection system
(PerkinElmer).
 
ELISA.
 
Multiplex cytokine detection for IL-10, MIP1
 
 
 
,
MCP-5, and RANTES was performed by Pierce Chemical Co.
with 24-h culture supernatants. The same supernatants were used
for mouse TNF ELISA (Duoset; R&D Systems).
 
Electrophoretic Mobility Shift Assays (EMSAs) and Supershift Anal-
yses.
 
EMSA was performed as previously described (29). For su-
pershift experiments, nuclear proteins were incubated with poly-
clonal antibodies against mouse protein p50 and p65 (Santa Cruz
Biotechnology, Inc.) for 30 min on ice before the addition of ra-
diolabeled oligonucleotide and gel electrophoresis.
 
Online Supplemental Material.
 
Table I shows MyD88-depen-
dent gene regulation in response to IFN-
 
 
 
, Table S2 shows gene
regulation in response to Mtb, and Table S3 shows sequences of
primers and probes for qRT-PCR. Fig. S1 shows gene regulation
in WT and MyD88
 
 
 
/
 
 
 
 macrophages in response to activation
with IFN-
 
 
 
, infection with Mtb, or both. Tables S1–S3 and
Fig. S1 are available at http://www.jem.org/cgi/content/full/
jem.20030603/DC1.
 
Results
 
Functional Activation of MyD88
 
 
 
/
 
  
 
Macrophages.
 
We be-
gan by testing MyD88’s contribution to macrophage acti-
vation at the functional level. Mouse macrophages acti-
vated with IFN-
 
  
 
can kill Mtb through a nitric oxide
(NO)-dependent mechanism. In contrast, nonactivated
macrophages produce little NO and exert a bacteriostatic
effect (7, 27). Accordingly, we examined nitrite accumula-
tion and bacterial survival in both resting and IFN-
 
 
 
–acti-
vated BMM
 
  
 
after infection with a disease-causing clinical
isolate of Mtb. In response to IFN-
 
  
 
and Mtb, WT macro-
phages produced similar amounts of NO per cell when
cells were plated at two different cell densities (
 
 
 
10
 
5 
 
cells/
cm
 
2 
 
and 1.5–2 
 
  
 
10
 
5 
 
cells/cm
 
2
 
; Fig. 1, A and B). As ex-
pected, activated WT macrophages killed intracellular Mtb
(Fig. 1 C). In contrast, production of NO by IFN-
 
 
 
–
treated, Mtb-infected MyD88
 
 
 
/  cells was dependent on
cell density (Fig. 1, A and B). At the higher cell density,
MyD88 /  cells produced nearly normal amounts of NO
and killed Mtb. Thus, macrophages can be functionally ac-
tivated by the combination of IFN-  and Mtb in the ab-
sence of MyD88 (Fig. 1 C). However, the effect of cell
density suggested that the response to exogenous activating
signals may depend on an autocrine factor whose amount
becomes limiting in the absence of MyD88.
Abnormal Phenotype of MyD88 /  Macrophages at Rest.
In the foregoing experiments, strikingly different morphol-
ogies of WT versus MyD88 /  macrophages were evident
under resting conditions, i.e., before the addition of IFN- 
or Mtb. WT macrophages after 6 d in culture were well
spread with the irregular, crescentic, or polygonal outline
typical of BMM . In contrast, MyD88 /  macrophages
cultured at lower density ( 104 cells/cm2) spread less well
and tended to adopt a spindle shape (to be illustrated subse-
quently). Flow cytometric analysis revealed that both WT
and MyD88 /  macrophages were homogeneous cell pop-
ulations with respect to expression of the following surface
markers, and moreover, the markers were expressed at sim-
ilar levels: CD14, Mac-1, CD18, CD16/32, and F4/80
(unpublished data). Thus, the different phenotypes of WT
and MyD88 /  macrophages could not be attributed to a
failure of MyD88 /  bone marrow cells to differentiate
into macrophages.
To develop a hypothesis for the mechanistic basis for the
phenotypic difference between WT and MyD88 /  mac-
rophages, we turned to global gene expression analysis,
comparing resting macrophages of both genotypes. All
statements regarding differential gene expression in this pa-
per refer to statistically significant differences in expression
levels for a given gene in two different macrophage popu-
Figure 1. Activation of WT and MyD88    BMM  in response to
IFN-  and Mtb. BMM  were seeded at a cell density of  105/cm2 (A) or
1.5–2   105/cm2 (B), activated with 100 U/ml IFN-  for 24 h, and infected
with Mtb at a multiplicity of infection (MOI) of 5. Production of nitrite,
an oxidation product of NO, is shown from WT macrophages (open
bars) and MyD88 /  macrophages (solid bars; means   SE of seven to
eight independent experiments). (C) WT and MyD88 /  macrophages at
a cell density of 2   105/cm2 were infected with Mtb at an MOI of 5.  ,
CFUs from nonactivated (resting) macrophages;  , CFUs from macro-
phages activated for 48 h with 100 U/ml IFN-  (means   SD of triplicates
in one experiment representative of three).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Role of MyD88 in Macrophage Activation by IFN-  and Mycobacteria 990
lations or for two different treatments of the same macro-
phage population, based on uncensored data from six inde-
pendent experiments. Statistically significant differences in
the ratios of expression for a given gene in treated versus
untreated samples (fold change) were used as an additional
criterion where so stated.
578 genes were differentially expressed between WT and
MyD88 /  macrophages at rest. Of these, 88 genes were at
least twofold more strongly expressed in resting WT than
resting MyD88 /  macrophages, and 31 genes were ex-
pressed at least twofold less. The impact of MyD88 on ex-
pression of 12 annotated genes that were among those with
the biggest differences in expression between resting WT
and resting MyD88 /  macrophages was confirmed by in-
dependent methods (Fig. 2). By real-time qRT-PCR, im-
mune responsive gene 1 (IRG1), serum amyloid A (SAA3),
IL-1 , IL-6, IL-10, TNF, IP10, RANTES, MIG, formyl
peptide receptor (FPR), and macrophage receptor with col-
lagenous domain (MARCO) were subnormally expressed
in resting MyD88 /  macrophages, whereas the chemokine
receptor CXCR4 was more highly expressed in MyD88 / 
macrophages than in the WT cells (Fig. 2 A). ELISA con-
firmed that less IL-10, TNF, and MIP1  were released by
resting MyD88 /  macrophages than by WT cells (Fig. 2
B). To exclude the possibility that the observed differences
between WT and MyD88 /  macrophages were due to
MyD88-independent genetic differences in the strain back-
ground (C57BL/6    129/SvJ, backcrossed six times to
C57BL/6), we analyzed gene expression of resting macro-
phages and IFN- –activated macrophages from C57BL/6
and 129Sv mice by qRT-PCR. The mRNA levels of
IRG1, FPR, MARCO, SAA3, IP10, MIG, and TNF were
similar in resting C57BL/6 and 129/SvJ macrophages and
treatment with IFN-   resulted in a similar induction of
iNOS, MIG, IP10, and IRG1 in WT macrophages of both
strains (unpublished data). In addition, WT macrophages of
both strains resembled WT C57BL/6   129/SvJ macro-
phages morphologically, showing none of the phenotypic
Figure 2. Comparison of resting WT
and MyD88    BMM . (A) Differential
gene expression between resting WT
and MyD88 /   macrophages (qRT-
PCR). RNA harvested from resting
WT (open bars) and MyD88 /  (solid
bars) BMM   and MyD88 /  BMM 
treated with 50 pg/ml TNF for 1 wk
(gray bars) was tested for gene expression
by qRT-PCR (means   SE of three
independent  experiments). (B) Differ-
ential cytokine/chemokine production
between resting WT and MyD88 / 
macrophages. Cell culture supernatant
was collected from resting WT (open
bars) and MyD88 /   (solid bars)
BMM . Production of TNF, MIP1 ,
and IL-10 was tested by ELISA (means  
SE of three independent experiments;
P   0.05 for each cytokine/chemokine).
(C) Morphology of WT and MyD88 / 
BMM . Bone marrow cells were iso-
lated from WT and MyD88 /  mice
and cultured in the presence of 20%
L929 cell–conditioned medium for 7 d.
Cells were either left untreated (WT and
MyD88 / ) or treated with 50 pg/ml
TNF (MyD88 / ) or 0.6  g/ml anti-
TNF (WT) for 48 h.T
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features of MyD88 /  macrophages. We conclude that the
observed differences between WT and MyD88 /  macro-
phages were MyD88 dependent.
Because expression of IL-1 , IL-10, and TNF was lower
in resting MyD88 /  cells, we tested whether the poor
spreading of MyD88 /  macrophages might be a conse-
quence of insufficient basal production of one of these cy-
tokines. We tested this by adding to MyD88 /  macro-
phage cultures the amounts of IL-10 or TNF that were
lacking in comparison to WT cultures, and by adding neu-
tralizing anti–IL-1 , anti–IL-1 , or anti-TNF antibodies to
WT cultures. Because MyD88 /  cells do not respond to
IL-1 (30), we did not add IL-1 to MyD88 /  cells. Addi-
tion of IL-10 had no effect on the morphology of
MyD88 /  cells, nor did neutralizing anti–IL-1 antibodies
affect the morphology of WT cells (unpublished data). In
contrast, anti-TNF antibody caused WT cells to spread
less and adopt the shape of untreated MyD88 /  cells.
Conversely, 50 pg/ml TNF improved the spreading of
MyD88 /  macrophages (Fig. 2 C). The ability of TNF to
enhance spreading of WT macrophages has been described
(31). Culturing the cells at a higher density (105/cm2 in-
stead of 104/cm2) also restored normal morphology (un-
published data). Moreover, the addition of low dose TNF
enhanced the expression of genes in otherwise untreated
MyD88 /  macrophages (Fig. 2 A). Thus, WT macro-
phages released low but functionally important amounts of
TNF under resting conditions. MyD88 /  cells were im-
paired in release of this cytokine.
Gene Induction and Suppression by IFN-   and/or Mtb.
Even though MyD88-deficient macrophages started out
differently than WT macrophages, if cultured at high den-
sity and exposed to IFN-  and Mtb they came to resemble
WT cells functionally with respect to anti-mycobacterial
activity and NO secretion (Fig. 1). However, the func-
tional assays measured only a few of the many changes that
macrophages undergo during activation. To monitor acti-
vation more broadly, we compared expression of  11,000
genes (about one third of the mouse genome) between
WT and MyD88 /  macrophages in response to IFN- ,
Mtb, and both stimuli together.
Microarray analysis of WT macrophages indicated that
 800 genes were regulated in response to IFN-   and
 600 genes were regulated in response to Mtb infection
(see Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20030603/DC1). A similar number of genes
were regulated in MyD88 /  macrophages, and the fold
change of regulation was similar in both genotypes (see
Fig. S1 B, available at http://www.jem.org/cgi/content/
full/jem.20030603/DC1). In macrophages of both geno-
types, the largest number of genes was regulated in re-
sponse to the combination of IFN-  and Mtb to an extent
that indicated synergy between the cytokine and the bac-
teria. For WT macrophages, the number of genes up-reg-
ulated and down-regulated by each stimulus or their
combination was almost equal. The same was true for
MyD88 /  cells. These findings extend a report with mac-
rophages of other genetic backgrounds (27), showing that
in addition to their well-known ability to activate gene
expression, IFN-  and Mtb are comparably active at sup-
pressing gene expression.
We then compared the regulation of individual genes by
IFN-  or Mtb in macrophages of the two genotypes. As
shown above, many genes were expressed differently in
resting WT and MyD88 /  macrophages. This resulted in
different expression levels in response to stimulation when
the fold change of regulation was similar in both macro-
phage genotypes. We therefore used two approaches to
identify genes that do or do not depend in part on MyD88
for their response to IFN-  and Mtb. One approach was
based on the comparison of gene expression levels in WT
and MyD88 /  macrophages after treatment with IFN- 
and Mtb (Fig. 3 A). Genes whose expression levels were
less than twofold different between WT and MyD88 / 
macrophages upon stimulation were classified as MyD88
independent. In contrast, genes whose expression levels
Figure 3. Specificity of gene regulation in WT and MyD88    macro-
phages. (A) Specificity based on expression level: Numbers within the
common sectors (red) of each Venn diagram represent the count of indi-
vidual genes whose expression level upon treatment was not statistically
significantly different between WT and MyD88 /  macrophages and was
less than twofold different between WT and MyD88 /  macrophages.
Numbers in the blue and green sectors represent genes whose expression
level upon treatment was statistically significantly different (P   0.05) and
greater than twofold different between WT and MyD88 /  macrophages.
Genes represented by blue sectors were regulated in WT macrophages
but not or significantly less regulated in MyD88 /  macrophages. Genes
represented in green sectors were regulated in MyD88 /  macrophages
but not or significantly less regulated in WT macrophages. (B) Specificity
based on fold regulation: Numbers within the common sectors (red) of
each Venn diagram represent genes whose fold change in expression
upon treatment was not statistically significantly different between WT
and MyD88 /  macrophages and whose fold change in expression in
response to treatment was less than twofold different between WT and
MyD88 /  macrophages. Numbers in the blue and green sectors represent
genes whose fold change in expression upon treatment was statistically
significantly different (P   0.05) and greater than twofold different
between WT and MyD88 /  macrophages upon treatment. Genes repre-
sented by blue sectors were regulated in WT macrophages but not or
significantly less regulated in MyD88 /  macrophages. Genes represented
in green sectors were regulated in MyD88 /  macrophages but not or
significantly less regulated in WT macrophages.T
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upon treatment were statistically significantly different and
more than twofold different in WT compared with
MyD88 /  macrophages, regardless of the fold regulation
within one genotype, were classified as MyD88 dependent.
By applying these criteria nearly half of the  800 genes
that were statistically significantly regulated in response to
IFN-  were categorized as MyD88 dependent or MyD88
independent. The remaining  400 genes were statistically
indeterminate with respect to their (in)dependence on
MyD88. “MyD88 dependent” in this context means that
the stimulus-induced change in expression was significantly
limited in the absence of MyD88, without implying an ab-
solute requirement for MyD88. In contrast, our second ap-
proach directly compared the fold change of expression of
significantly regulated genes in macrophages of the two ge-
notypes without regard to the expression levels attained
(Fig. 3 B). To our surprise, both of these approaches identi-
fied many genes that were MyD88 dependent in their re-
sponse to IFN- . This group of genes was larger when de-
fined by the impact of MyD88 on gene expression levels
(105 genes; Fig. 3 A and see Table S1, available at http://
www.jem.org/cgi/content/full/jem.20030603/DC1) than
when defined by the impact of MyD88 on fold regulation
(50 genes; Fig. 3 B). Next, we turned to independent ex-
perimental approaches to confirm these observations and
unveil mechanisms underlying the impact of MyD88 on
gene regulation in response to IFN- .
MyD88-dependent Gene Regulation by IFN- : Role of
TNF. Fig. 4 shows the extent of regulation of genes
whose responses to IFN-  illustrate partial dependence on,
or independence of, MyD88. Many of these genes were
induced by IFN-  in MyD88 /  macrophages with a fold
change comparable to that of WT cells (Fig. 4 A). None-
theless, their expression in response to IFN-  remained
significantly and substantially subnormal in MyD88 / 
macrophages (Fig. 4 B) as confirmed by qRT-PCR,
Western blot, and ELISA (Fig. 5). Thus, qRT-PCR con-
firmed induction of iNOS, IRG1, IP10, MIG, RANTES,
and IL-6 by IFN-  in WT macrophages. Induction of
these genes was severely reduced in MyD88 /  macro-
phages (Fig. 5 A). Western blot showed iNOS induction
in WT but not MyD88 /  macrophages after 72 h of in-
cubation with IFN-  alone (Fig. 5 B), as opposed to the
result when cells were treated with IFN-  in combination
with Mtb (Fig. 1). ELISA demonstrated MCP-5 induction
by IFN-   in WT macrophages but not in MyD88 / 
macrophages (Fig. 5 C).
Next, we tested whether basal TNF deficiency contrib-
uted to the hyporesponsiveness of MyD88 /  macrophages
to IFN- . We added 50 pg/ml TNF to MyD88 /  macro-
phages and 0.6  g/ml anti-TNF to WT macrophages be-
fore IFN-  treatment, and then tested gene expression by
qRT-PCR. For most of the genes tested, the addition of
low dose TNF potentiated their expression in MyD88 / 
macrophages after IFN-  treatment (Fig. 5 A). Conversely,
WT cells pretreated with TNF neutralizing antibody re-
sponded to IFN-  with reduced gene induction (Fig. 5 A).
Thus, basal expression of TNF markedly affected macro-
phage responses to IFN- .
Hyporesponsiveness of MyD88 /  Macrophages to IFN- 
Correlates with Subnormal Basal NF- B Activity. To ad-
dress the mechanism by which MyD88 enhances macro-
phage responses to IFN- , we tested the impact of MyD88
on STAT1 activation after IFN-  treatment. Tyr-701 phos-
phorylation of STAT1 in response to IFN-  was normal in
MyD88 /  macrophages (Fig. 6 A), demonstrating the integ-
rity of early IFN-  signaling events in these cells. This sug-
gests that although STAT1 activation is necessary, it is not
sufficient for full-scale gene regulation by IFN- . Transcrip-
tion factors other than STAT1 also contribute, and a relative
lack of such factors might account for the hyporesponsiveness
of MyD88 /  macrophages to IFN- . With this in mind, we
inspected the promoter regions of 16 annotated genes that
were among the most strongly regulated by IFN-  in WT
macrophages and whose response to IFN-  was subnormal
in MyD88 /  cells. All of these promoters contained binding
sites for NF- B as well as for IFN- –recruited or –induced
transcription factors such as STAT1, IFN regulatory factor 1,
or IFN regulatory factor 3. We hypothesized that basal NF-
 B activity in resting WT macrophages could synergize with
IFN-  for maximal gene expression. In contrast, MyD88 / 
macrophages might be deficient in this basal NF- B activity
(Fig. 6 B). This would contribute to subnormal gene expres-
Figure 4. Quantitative regulation of individual genes in WT and
MyD88    macrophages in response to IFN- . Data are means from six
microarray experiments. RNA was isolated from resting macrophages and
from macrophages treated for 48 h with 100 U/ml IFN- . Red squares
indicate genes regulated in both WT and MyD88 /  macrophages. Blue
squares indicate genes whose regulation was dependent on MyD88.
MyD88-dependent genes were defined as genes whose expression level in
response to IFN-  in MyD88 /  macrophages was statistically different
(P   0.05) from that in WT macrophages and at least twofold less than in
WT macrophages. Genes regulated with high fold changes and genes of
special interest are named. In A, the fold regulation in response to IFN- 
in WT macrophages is compared with fold regulation in response to
IFN-  in MyD88 /  macrophages. Fold regulation is calculated as ratio
of mean signal intensity of expression of the gene in question in IFN- –
treated WT or MyD88 /  macrophages over its mean signal intensity in
untreated macrophages of the same genotype. In B, gene expression levels
in IFN- –treated WT and IFN- –treated MyD88 /  macrophages are
compared. Gene expression levels are normalized by taking the mean signal
intensity of expression of the gene in question in IFN- –treated WT or
MyD88 /  macrophages and dividing that value by the mean signal intensity
in untreated WT macrophages. GBP, guanylate nucleotide binding protein;
H1, MHC class I Qa-TIa; OSF2, osteoblast-specific factor 2; SPI2, serine
protease inhibitor 2; Upase, uridine phosphorylase. See text for other
abbreviations.T
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sion in resting MyD88 /  macrophages and impaired gene
induction by IFN- .
To test this hypothesis, EMSAs were performed on nu-
clear extracts from resting WT and MyD88 /  macro-
phages. WT cells indeed displayed a higher basal activity of
NF- B than MyD88 /  macrophages (Fig. 6 C). Supershift
analyses with monospecific antibodies identified p65/p50
heterodimers and p50 homodimers.
Mtb Regulates Macrophage Gene Expression by Both
MyD88-dependent and MyD88-independent Pathways. De-
spite their defect in IFN- –induced gene expression,
MyD88 /  macrophages responded to Mtb far better than
anticipated. As shown in Fig. 7 and Table S2, available at
http://www.jem.org/cgi/content/full/jem.20030603/DC1,
the vast majority of genes showing substantial induction by
Mtb in WT macrophages were similarly induced in macro-
phages lacking MyD88. These observations were confirmed
by qRT-PCR and ELISA. Thus, iNOS, COX-2, IP10,
MIG, RANTES, IRG-1, argininosuccinate synthetase 1, and
chemokines JE and KC were up-regulated by Mtb in both
WT and MyD88 /  macrophages to a similar expression
level (Fig. 8 A), as confirmed for RANTES by ELISA (Fig. 8
C). In contrast, MyD88 was required for Mtb to induce IL-
1  and IL-6 (Figs. 7 and 8 B), cytokines that play a critical
role in the immune response to and control of Mtb (32–35).
Similarly, cell surface receptors FPR and MARCO and acute
phase reactant SAA3 were up-regulated by Mtb in WT mac-
rophages, but their expression in MyD88 /  macrophages in
response to Mtb was minimal (Fig. 8 B). The situation was
similar for MCP-5, as confirmed by ELISA (Fig. 8 C).
Discussion
These results reveal an MyD88-dependent process of
self-priming in resting macrophages, the importance of
Figure 5. Confirmation of MyD88-dependent
gene regulation in response to IFN- . (A) Cells
were left untreated (WT and MyD88 / ) or
treated with 50 pg/ml TNF (MyD88 / ) or
0.6  g/ml anti-TNF (aTNF; WT) for 1 wk
followed by IFN-  treatment (100 U/ml) for
4 h. RNA was assayed by qRT-PCR. Gene
expression is reported as copy number per
10,000 copies of GAPDH on a log10  scale
(means of three independent experiments  
SE). Numbers atop each bar indicate the fold
change of gene expression after treatment com-
pared with expression of the same gene in un-
treated WT cells. If expression was not detectable
(for example, iNOS in untreated WT cells), the
value of 1 copy per 10,000 GAPDH was assigned
and fold change was conservatively estimated
based on this value. All qRT-PCR data in this
paper are presented in the same way. Open bars
depict gene expression in WT cells and solid
bars depict gene expression in MyD88 /  cells.
(B) Cell lysates were collected over a 72-h time course of IFN-  treatment. Western blot was performed with anti-iNOS antibody. The stripped membrane was
blotted with anti-HSP90 antibody as a loading control. Data are representative of three experiments. (C) MCP-5 production was measured by ELISA in
cell culture supernatant 24 h after treatment with 100 U/ml IFN-  (means of three experiments   SE; P   0.05). Open bars depict gene expression in
WT cells and solid bars depict gene expression in MyD88 /  cells.
Figure 6. One potential mechanism of hyporesponsiveness of
MyD88    BMM  to IFN- . (A) Western blot to detect phosphorylated
STAT1 (pY-STAT1). WT and MyD88 /  BMM  were untreated or
treated with 100 U/ml IFN- . Cell lysates were harvested 15 min and 2 h
after IFN-  treatment. Western blot was performed with anti-pTyr701
STAT1. (B) Hypothetical model for hyporesponsiveness of MyD88 / 
BMM  to IFN- . The horizontal line represents the plasma membrane.
Endogenous ligands that activate the MyD88 pathway might be produced
by the macrophage (e.g., IL-1, IL-18, heat shock proteins) or might be
produced by the action of macrophages on the extracellular matrix (e.g.,
fibronectin and fibronectin fragments). MyD88-dependent signaling in
response to these ligands may drive the NF- B–dependent expression of
additional stimuli (e.g., TNF, SAA3), which can also help sustain NF- B
activation. The resulting activation of NF- B in ostensibly resting macro-
phages can synergize with IFN- –activated signals (e.g., STAT1) in driving
IFN- –dependent gene expression. (C) Detection of NF- B by EMSA.
Nuclear extracts were harvested from resting WT and MyD88 /  macro-
phages and equal amounts of protein were subjected to EMSA. Data are
representative of three experiments.T
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MyD88-dependent autocrine signals in macrophage activa-
tion by IFN- , and the ability of macrophages to sense the
presence of viable Mtb with little help from MyD88.
Taken together, these three observations suggest that
MyD88 plays a different role in macrophage activation than
previously understood. The essentiality of MyD88 for full-
scale activation by IFN-  and the relative dispensability of
MyD88 for activation by Mtb were equally unexpected.
Compared with resting WT macrophages, nonactivated
MyD88-deficient macrophages appeared morphologically
quiescent and displayed subnormal expression of many
genes in the face of reduced basal NF- B activity. NF- B
activity has been observed previously in unstimulated mac-
rophages (36). Our study suggests that impaired NF- B
activity in resting MyD88 /  macrophages might be one
explanation for the functional differences between nonacti-
vated WT and MyD88 /  cells.
Lower basal NF- B activity in MyD88 /  macrophages
also appeared to contribute to the impaired transcriptional
response to IFN-  in MyD88 /  macrophages. MyD88 / 
cells had no defect in early steps in IFN-  signaling. How-
ever, maximal activation of IFN- –induced genes often results
from synergy between NF- B–mediated and IFN- –depen-
dent signals. Preincubation with TNF, an NF- B activat-
ing stimulus, potentiated gene expression in MyD88 / 
macrophages in response to IFN- . A contribution of
spontaneously produced, autocrine-acting cytokines to
macrophage activation has been noted before (37), but a
central role for MyD88 in this process was not recognized.
Two interrelated mechanisms may account for MyD88-
dependent NF- B activity in resting WT macrophages.
First, there might be substances present in cultures of resting
macrophages that can activate NF- B through signal trans-
duction pathways that are dependent on MyD88. Stimuli of
endogenous origin that signal through MyD88 include IL-
1 , IL-1 , IL-18,  -defensin 2 (38), minimally modified
low density lipoproteins (39), necrotic cells (40, 41), and
heat shock proteins (42). For example, monocytes and mac-
rophages express mRNA for IL-1  and TNF as they adhere
to extracellular matrix (43, 44). Second, there might be sub-
Figure 7. Comparison of gene regulation in WT and MyD88    macro-
phages in response to Mtb. Data are averages of six microarray experiments.
RNA was isolated from resting macrophages and from macrophages 24 h
after infection with Mtb. Red squares indicate genes regulated in WT and
MyD88 /  macrophages. Blue squares indicate genes whose regulation
was dependent on MyD88. MyD88-dependent genes were defined as
genes whose expression level in response to Mtb in MyD88 /  macro-
phages was statistically different (P   0.05) from that in WT macrophages
and at least twofold less than in WT macrophages. Genes regulated with
high fold changes and genes of special interest are named. In A, the fold
regulation in response to Mtb in WT macrophages is compared with fold
regulation in response to Mtb in MyD88 /  macrophages. Fold regulation is
calculated as ratio of mean signal intensity of expression of the gene in
question in Mtb-treated WT and MyD88-deficient macrophages over its
mean signal intensity in uninfected macrophages of the same genotype. In
B, gene expression levels are normalized for Mtb-infected macrophages
by taking the mean signal intensity of expression of the gene in question
in infected WT or MyD88 /  macrophages and dividing that value by
the mean signal intensity in uninfected WT macrophages. DAF, decay-
accelerating factor; IGFBP, insulin-like growth factor binding protein;
GARG-16, glucocorticoid-attenuated response gene 16; LIX, LPS-induced
C-X-C chemokine. See text for other abbreviations.
Figure 8. MyD88-independent and MyD88-
dependent gene regulation in response to Mtb. (A
and B) Gene regulation measured by qRT-PCR.
RNA was harvested from WT and MyD88 / 
BMM  4 h after Mtb infection and assayed for
gene expression by qRT-PCR. Data are means of
three independent experiments   SE. Open bars
depict gene expression in WT cells and solid
bars  depict gene expression in MyD88 /  cells.
MyD88-independent (A) and MyD88-dependent
(B) gene regulation in response to Mtb. (C)
MyD88-independent production of RANTES and
MyD88-dependent production of MCP-5 in in-
fected macrophages. Cells were infected with Mtb
for 24 h. Cell culture supernatants were assayed for
RANTES and MCP-5 by ELISA (means of three
experiments   SE; P   0.05). Open bars depict
gene expression in WT cells and solid bars depict
gene expression in MyD88 /  cells.T
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stances that activate NF- B through pathways that do not
involve MyD88. However, macrophages may require
MyD88 to respond to signals that elicit the production of
these substances. For example, under resting conditions,
WT macrophages secreted TNF and SAA3, but MyD88 / 
macrophages released less of these proteins. TNF activates
NF- B via the TNF receptor, whereas SAA3 activates NF-
 B through the receptor for advanced glycation end-prod-
ucts (45). Neither the TNF receptor nor receptor for ad-
vanced glycation end-products depend on MyD88, but
MyD88 appears to have helped mediate the signals that led
to secretion of TNF and SAA3 by resting macrophages. Fi-
nally, MyD88 may regulate additional pathways besides
NF- B that can also modulate the response to IFN-  (Sun,
D. and Ding, A., personal communication).
Active self-priming of macrophages for subsequent acti-
vation is fundamentally different from an earlier concept of
macrophage activation, in which the resting cell was pas-
sive and the exogenous-activating stimuli microbial prod-
ucts and lymphocyte-derived mediators were called “prim-
ing” and “activating” agents, depending on the order of
their addition (3, 8, 46, 47).
Despite its marked effect on the macrophage response to
IFN- , subnormal basal NF- B activity had little impact
on the ability of MyD88 /  macrophages to respond to
Mtb. Most macrophage genes that were regulated by Mtb
responded independently of MyD88, even genes that were
subnormally expressed in resting MyD88 /  macrophages.
Unlike the response to IFN-  on the part of MyD88 / 
macrophages, wherein many genes failed to reach expres-
sion levels comparable to that of the WT cells, expression
of Mtb-induced genes in MyD88 /  macrophages was of-
ten quantitatively similar to that of the WT cells.
The MyD88-independent pathways by which Mtb acti-
vates the macrophage remain to be identified. Mycobacte-
rial products such as lipoproteins, LAM, and phosphati-
dylinositol stimulate macrophages via TLR2 (25, 26).
However, a TLR2-dependent, MyD88-independent signal
transduction pathway has not been described. Live Mtb ac-
tivates macrophages not only through TLR2 but also
through TLR4 (48). Some of the genes (e.g., IRG1, IP10,
GARG16) that were regulated by Mtb in an MyD88-inde-
pendent manner in our study were also induced by LPS via
an MyD88-independent pathway (16, 49), and it is possible
that Mtb also activates this pathway via TLR4. NO pro-
duction and anti-mycobacterial activity were retained in
activated, Mtb-infected MyD88 /  cells. This is in agree-
ment with MyD88-independent activation of the iNOS
promoter in Mtb-stimulated macrophage-like cells (50).
Many receptors besides TLRs have been shown to mediate
interactions of Mtb with macrophages. The mannose re-
ceptor, complement receptors, scavenger receptors, CD14,
CD44, and Fc  receptors may all participate in phagocyto-
sis of Mtb by macrophages (51, 52). Engagement of the
mannose receptor triggers production of reactive oxygen
intermediates by macrophages as well as induction of ma-
trix metalloproteinase-9 in response to Mtb (53, 54). CD14
is involved in LAM-stimulated release of TNF, IL-1, and
IL-8 (55, 56). Dendritic cell–specific ICAM-3–grabbing
nonintegrin mediates uptake of Mtb by human monocyte-
derived dendritic cells and transmits signals that interfere
with their maturation (57, 58). Dendritic cell–specific
ICAM-3–grabbing nonintegrin has also been found on
macrophages (59) and thus may transmit Mtb-induced sig-
nals in macrophages as well. By whichever receptors, it is
clear that live, intact Mtb can activate macrophages in large
part independently of MyD88.
On the other hand, the MyD88-dependent component
of the macrophage response to Mtb included induction of
IL-1  and IL-6, which play critical roles in the immune re-
sponse to and control of Mtb in vivo. IL-6–deficient mice
displayed enhanced susceptibility to infection with Mtb
(32), which might be related to impaired production of
IFN-  during the early phase of infection, before adaptive
T cell immunity has fully developed (35). IL-1  and IL-1 
double knockout mice and IL-1R type I–deficient mice
showed increased bacterial growth and defective granuloma
formation after infection with Mtb (33, 34). Thus, our re-
sults with cultured macrophages do not predict the course
of experimental tuberculosis in MyD88 /  mice, where
some critical cells will respond to Mtb before IFN-  is pro-
duced, some will encounter IFN-  but not Mtb, and some
will react to both.
In conclusion, these results demonstrate that resting pri-
mary mouse macrophages prime themselves in an MyD88-
dependent manner via autocrine factors, including TNF, to
respond to a classical activating signal, IFN- . MyD88-
dependent basal activation of NF- B appears to be one of
the mechanisms by which MyD88 scales the macrophage
response to IFN- . Finally, it appears that live, virulent
Mtb activates macrophages in large part via TLR adaptors
other than MyD88 or via receptors other than TLRs.
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